Crescent Capital moves on new target after Pacific Smiles battle
Sydney-based private equity firm Crescent Capital is capitalising on consolidation opportunities amid weak economic conditions.
Sydney-based private equity firm Crescent Capital is capitalising on consolidation opportunities amid weak economic conditions.
John Wylie’s Tanarra Capital is believed to be quietly backing Bain Capital’s bid for Insignia Financial behind the scenes.
Virgin Australia’s private equity owner would view the much-hyped DigiCo float’s flop with some trepidation for its own plans for an IPO in 2025.
Brookfield’s head office is understood to be increasingly of the opinion Healthscope isn’t a good investment.
The company behind some of the nation’s most celebrated dining venues is now owned by its lender, and the newly released accounts show why it took control.
Amcor’s $13bn acquisition of Berry Global Group appears likely to gain majority approval from the target’s shareholders.
Bain Capital’s $2.7bn offer for Insignia Financial could begin a bidding war for the wealth manager and Kohlberg Kravis Roberts may be an interested party.
Car dealership owner Peter Warren could be ripe for takeover, according to analysts at Moelis.
Brookfield may soon move to further distance itself from Healthscope, although sources close to the private equity owner are playing down the prospect of voluntary administration.
Insignia has group funds under management and administration of $319.6bn.
Original URL: https://www.theaustralian.com.au/author/bridget-carter/page/7